TrivarX Ltd logo

TrivarX Ltd

ASX:TRI (Australia)  
A$ 0.03 (+4%) Apr 24
At Loss
P/B:
1.04
Market Cap:
A$ 8.80M ($ 5.75M)
Enterprise V:
A$ 8.55M ($ 5.58M)
Volume:
66.59K
Avg Vol (2M):
683.73K
Also Trade In:
Volume:
66.59K
At Loss
Avg Vol (2M):
683.73K

Business Description

Description
TrivarX Ltd is a health technology company developing AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions. Trivarx's clinical research has enabled the development of cutting-edge proprietary algorithms for spectral analyses of sleep architecture and heart rate variability.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 5.1
Equity-to-Asset 0.89
Debt-to-Equity 0.01
Debt-to-EBITDA -0.02
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -16.3
Distress
Grey
Safe
Beneish M-Score -4.02
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 67.66
9-Day RSI 51.89
14-Day RSI 47.42
6-1 Month Momentum % 45
12-1 Month Momentum % -3.33

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.35
Quick Ratio 0.35
Cash Ratio 0.31

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -60.8
Shareholder Yield % -58.22

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -12172.73
Net Margin % -13959.09
FCF Margin % -20850
ROE % -50.52
ROA % -43.42
ROIC % -28.44
ROC (Joel Greenblatt) % -5878.42
ROCE % -50.34

GF Value Rank

Name Current Vs Industry Vs History
PB Ratio 1.04
EV-to-EBIT -2.29
EV-to-EBITDA -2.52
EV-to-Revenue 388.68
EV-to-FCF -1.72
Earnings Yield (Greenblatt) % -43.64
FCF Yield % -52.13